Paul Tudor Jones Medtronic PLC Call Options Transaction History

Tudor Investment Corp Et Al

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$78.71 - $87.02 $976,003 - $1.08 Million	-12,400 Reduced 23.44%	40,500 $3.19 Million
Q1 2024 May 15, 2024	BUY	$82.84 - $88.09 $1.77 Million - $1.89 Million	21,400 Added 67.94%	52,900 $4.61 Million
Q4 2023 Feb 14, 2024	BUY	$69.43 - $83.43 $486,010 - $584,010	7,000 Added 28.57%	31,500 $2.59 Million
Q3 2023 Nov 15, 2023	BUY	$78.22 - $90.4 $1.38 Million - $1.6 Million	17,700 Added 260.29%	24,500 $1.92 Million
Q2 2023 Aug 14, 2023	BUY	$79.47 - $91.38 $540,396 - $621,384	6,800 New	6,800 $599,000
Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $1.52 Million - $1.75 Million	20,000 Added 425.53%	24,700 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $379,525 - $447,957	4,700 New	4,700 $379,000

2,238

1.04B

7.1M

4.39M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $119B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.